SAP Helps Simplify Personalized Medicine to Fight Cancer and Other Illnesses

CHICAGO, April 13, 2015 /PRNewswire/ -- SAP SE (NYSE: SAP) today announced an expanded commitment and significant progress in its effort to make the benefits of personalized medicine available to more patients fighting cancer and other serious illnesses. The announcement was made at HIMSS15, being held April 12–16 in Chicago.

"We're focused on improving people's lives with simple solutions to complex problems, and we recognize that the most universally relevant challenges are in healthcare," said Martin Kopp, vice president and head of the global healthcare industry unit, SAP. "Co-innovating with partners of all sizes on our technology platforms, we're working across the board to improve health and make a rapid, direct impact on quality of life."

Transforming Cancer CareThe American Society for Clinical Oncology recently announced that its wholly owned subsidiary, CancerLinQ LLC, has chosen the SAP HANA® platform for the development of ASCO's CancerLinQ™. CancerLinQ is intended to be a groundbreaking health information technology (HIT) platform that will harness Big Data to deliver high-quality care to patients with cancer. It is one of the only major cancer data initiatives being developed and led by physicians with the primary purpose of improving patient care.

"CancerLinQ is the kind of innovation needed to advance the vision of precision medicine," said Dr. Peter Paul Yu, MD, president, ASCO. "By collecting and analyzing data from almost every U.S. cancer patient, CancerLinQ is intended to uncover personalized insights that will benefit oncology practices and patients across the United States – no matter what their affiliation or choice of electronic health record systems may be – and accelerate medical advances."

SAP also announced in June 2014 that it will offer a personalized treatment recommendation service to its employees fighting cancer. The service, called COPE (Corporate Oncology Program for Employees) and offered through a partnership with MOLECULAR HEALTH GmbH, delivers decision support for targeted cancer treatments, aiming for better results with fewer side effects.

The ASCO relationship builds on last year's early deployment of Medical Research Insights, a service based on an oncology clinical data platform that SAP developed in partnership with the German National Center for Tumor Diseases (NCT) and now in use for testing purposes at its facilities in Heidelberg, Germany. At this time, Medical Research Insights is intended for use in medical research only and not the treatment of patients.

The COPE service will initially be used for the benefit of SAP employees with a cancer diagnosis. In the spirit of SAP's mission of making the world run better, it is SAP's hope that providing this service will create a standard that will be adopted by other employers. The service has already been made available for employees in the United States and Germany, with the intent for employees in additional countries to gain from this benefit in the near future.

Enabling Targeted Care with AnalyticsIn another example, Dartmouth-Hitchcock health system (D-H) is working with analytics solutions from SAP and the SAP HANA platform to help predict surgical outcomes for its patients experiencing chronic knee pain. The initiative, named GreenCare, is aimed at improving the patient care experience by allowing physicians to help improve surgical outcomes, address costs and help avoid unnecessary surgeries. GreenCare combines real-time data analytics with patient-focused, science-based surveys to give patients the best outcomes.

Making Sense of Big DataTo deliver highly targeted care, research and healthcare organizations need technology that gathers and shares very large volumes and varieties of health data and information. PHEMI, an SAP partner that offers an enterprise-grade Big Data warehouse, supports healthcare organizations with a solution that helps researchers and clinicians find the information they need quickly and easily.

"Healthcare organizations are transforming unprecedented volumes and types of data into medical insights. The challenge isn't just to gather the information, but to organize it and make it available to researchers across the country or around the globe and at the same time enforce data sharing and consent agreements," said David Delaney, chief medical officer, SAP (Americas).

For more information, visit the SAP News Center. Follow SAP on Twitter at @sapnews.

About SAPAs market leader in enterprise application software, SAP (NYSE: SAP) helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device – SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP applications and services enable more than 282,000 customers to operate profitably, adapt continuously and grow sustainably. For more information, visit www.sap.com.

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP's future financial results are discussed more fully in SAP's filings with the U.S. Securities and Exchange Commission ("SEC"), including SAP's most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.

© 2015 SAP SE. All rights reserved. SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see http://www.sap.com/corporate-en/legal/copyright/index.epx#trademark for additional trademark information and notices.

For customers interested in learning more about SAP products: Global Customer Center: +49 180 534-34-24United States only: 1 (800) 872-1SAP (1-800-872-1727)

For more information, press only:Mat Small, SAP, +1 (510) 684-3552, [email protected], PDTSAP News Center press room; [email protected] Michael Reilly, FleishmanHillard, +1 (202) 828-9742, [email protected], EDT

Logo - http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sap-helps-simplify-personalized-medicine-to-fight-cancer-and-other-illnesses-300064735.html

SOURCE SAP SE